Monthly Archives: March 2019

MOLECULAR PARTNERS TO PRESENT AT THE COWEN AND COMPANY 39th ANNUAL HEALTHCARE CONFERENCE

By | Uncategorized | No Comments

In its presentation at the Cowen and Company 39th Annual Healthcare Conference, Molecular Partners highlights the progress on its clinical DARPin® compounds, discuss MP0310 in its strategic partnership with Amgen and update on the initiation of a research project to explore DARPin® molecules targeting peptide MHC complexes supported by Gilead

Read More